AC
CTNM

Aaron Cowen’s Contineum Therapeutics CTNM Stock Holding History

Aaron Cowen’s Portfolio CTNM Stock Details CTNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.6M Hold
2,841,334
– – 0.85% 37
2026
Q1 		$37.1M Hold
2,841,334
– – 0.95% 37
2025
Q4 		$32.5M Buy
2,841,334
+1,121,334
+65% +$12.8M 0.67% 46
2025
Q3 		$20.2M Hold
1,720,000
– – 0.52% 54
2025
Q2 		$6.83M Hold
1,720,000
– – 0.21% 59
2025
Q1 		$12M Hold
1,720,000
– – 0.45% 53
2024
Q4 		$25.2M Hold
1,720,000
– – 0.86% 41
2024
Q3 		$32.9M Sell
1,720,000
-333,334
-16% -$6.39M 1.05% 36
2024
Q2 		$36.2M Buy
+2,053,334
New +$33.1M 1.33% 24

Other funds holding CTNM

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Aaron Cowen's CTNM Position: Q2 2026 in Review

Aaron Cowen held its Contineum Therapeutics (CTNM) position steady in Q2 2026 at 2,841,334 shares worth $46.6M. The position accounts for 0.85% of the portfolio, ranked #37.

Aaron Cowen first reported a position in CTNM in Q2 2024 and has held it in 9 quarters since. 101 funds tracked by Wall St. Rank hold CTNM as of Q2 2026.

  • Aaron Cowen held 2,841,334 shares of Contineum Therapeutics worth $46.6M as of Q2 2026.
  • Aaron Cowen left its Contineum Therapeutics share count unchanged in Q2 2026.
  • Contineum Therapeutics made up 0.85% of Aaron Cowen's portfolio in Q2 2026, its #37 holding.
  • Aaron Cowen first reported a position in Contineum Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • 101 funds tracked by Wall St. Rank held Contineum Therapeutics as of Q2 2026.

Based on Suvretta Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.